Sigma Healthcare concluded the retail component of its entitlement offer, generating approximately $223 million to facilitate the merger with private retailer Chemist Warehouse and enable its listing on the ASX.
The offer, which closed on Jan. 19, attracted over 4,000 applications for retail entitlements, including Sigma's largest shareholder, HMC Capital Partners Fund.
The funds raised will support the issuance of 111 million new shares at the offer price of 70 cents.
The completion of the deal is contingent on various regulatory approvals, including those from the Australian Consumer and Competition Commission.